CRP and metabolic dysfunction-associated steatotic liver disease: However, meta-analyses of RCTs reported nominally statistically significant pooled results for only 15 of 37 healthy outcomes (including alanine aminotransferase and spartate aminotransferase indicators in adult patients with NAFLD, oxidative stress and inflammation indicators in hemodialysis patients, serum CRP concentrations, CIPN, contrast-induced acute kidney injury, endothelial function, systolic blood pressure, myocardial infarction and fatal myocardial infarction, and severity of mastalgia).